Sunshine Biopharma (SBFM) Cash & Equivalents Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFM) Cash & Equivalents Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 21.81% |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 11.05% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -4.92% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 7.80% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 19.10% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 12.11% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 27.55% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 13.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 32.82% |
| 10 | Sunshine Biopharma | 1.60 Mn | -12.15 Mn | 2.43 Mn | -11.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.34% |
| Mar 31, 2026 | -28.97% |
| Dec 31, 2025 | -25.23% |
| Sep 30, 2025 | -38.78% |
| Jun 30, 2025 | -37.26% |
| Mar 31, 2025 | -14.89% |
| Dec 31, 2024 | 67.94% |
| Sep 30, 2024 | 72.29% |
| Jun 30, 2024 | 87.88% |
| Mar 31, 2024 | 113.30% |
| Dec 31, 2023 | 154.37% |
| Sep 30, 2023 | 237.85% |
| Jun 30, 2023 | 513.14% |
| Mar 31, 2023 | 1,113.09% |
| Dec 31, 2022 | 713.78% |
| Sep 30, 2022 | 690.91% |
| Jun 30, 2022 | 938.31% |
| Mar 31, 2022 | 417.42% |
| Dec 31, 2021 | 164.49% |
| Sep 30, 2021 | 271.82% |